Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent
Cureus · 20.04.2026
DOI: 10.7759/cureus.107424 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 20.04.2026. Verfasst von Pradeep Khanal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Hematology and Oncology, Henry Ford Health, Detroit, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology and Oncology, Henry Ford Health, Detroit, USA.
- Internal Medicine, University of Michigan Health-Sparrow, Lansing, USA.
- Internal Medicine, Corewell Health William Beaumont University Hospital, Royal Oak, USA.
- Hematology and Oncology, St Joseph Mercy Hospital, Ypsilanti, USA.
Zitieren
APA
Khanal, P., Sapkota, S., Karageorgiou, I., & Al Baghdadi, T. (2026). Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent. Cureus. https://doi.org/10.7759/cureus.107424
Vancouver
Khanal P, Sapkota S, Karageorgiou I, Al Baghdadi T. Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent. Cureus. 2026. doi:10.7759/cureus.107424
BibTeX
@article{Khanal2026,
author = {Khanal, Pradeep and Sapkota, Suhail and Karageorgiou, Ioannis and Al Baghdadi, Tareq},
title = {Hypofibrinogenemia Induced by Eravacycline: A Rare but Serious Adverse Effect of a Novel Antimicrobial Agent},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.107424}
}
EUVIMED